The development of gene therapy drug delivery systems includes the development of multiple modes of drug delivery such as inhalation, transdermal, and injection. The development of innovative drug delivery systems can expand the range of applications for gene therapy agents and increase the safety and efficacy of gene therapy formulations.
CD Formulation specializes in the development of gene therapy drug delivery systems. We can integrate cutting-edge materials science, carrier engineering, and formulation technologies to ensure safety, efficacy and scalability based on the characteristics and needs of our clients' programs, with the expectation of optimal drug delivery.
The establishment of sophisticated gene therapy drug delivery systems is essential to address the challenge of delivering genetic material safely and efficiently to specific cells or tissues. These systems significantly impact the effectiveness as well as the safety of gene therapy agents. For instance, the development of injectable, transdermal, and inhalation drug delivery systems can further the research on targeted, non-invasive drug delivery to the respiratory system, offering a promising avenue for gene therapy for diseases related to the respiratory system. As a non-invasive technique, transdermal drug delivery devices can assure targeted or prolonged release of genetic material by avoiding obstacles like the gastrointestinal tract and first-pass digestion. For accurate systemic or localized gene therapy drug administration, the development of injectable drug delivery systems has proven to be even more crucial. In our research and development of gene therapy drug delivery systems, we insist on focusing on important issues such as drug biodistribution, stability, and immune response, to maximize the potential of gene therapy formulations in practical applications.
With a wealth of formulation development experience, we continue to advance the field of gene therapy drug delivery system development and are dedicated to offering our clients safe and effective gene therapy agent delivery system solutions. We specialize in developing gene therapy drug delivery systems for the top pharmaceutical companies. To guarantee optimal drug delivery and therapeutic results, our gene therapy drug delivery systems will be designed and developed with your project's demands and characteristics in mind. These considerations will include targeting, biostability, drug release rate, application locations, and many other criteria. To achieve precise, long-lasting, and safe drug release of molecules into target cells or tissues, our skilled technical team also continuously optimizes the gene therapy drug delivery system using a range of cutting-edge technologies and techniques, including nanotechnology and microneedle technology.
The development process of a gene therapy drug delivery system involves multiple steps, and we can formulate the corresponding development process for different drug delivery modes of our customers, and the following are some of the key development processes when we develop a gene therapy drug delivery system.
Fig.2 Our development process of gene therapy formulation drug delivery system. (CD Formulation)
Technologies & Platforms | Content Description |
---|---|
Nanoformulation technology | Nanoemulsion, lipid-based nano-vesicles, lipid nanoparticles (LNP) and other nanoformulations can greatly enhance the penetration of drugs into the skin and improve the transdermal efficiency of drugs due to their nanoscale size and unique physical and chemical properties. |
Targeted gene delivery technology | A new lipid carrier modified with dual ligands of transfer protein and hyaluronic acid is used for targeted gene delivery. It aims to accurately deliver gene therapy drugs to specific cells or tissues to improve the efficacy of gene therapy preparations and reduce side effects. |
Microneedle technology | This is a new type of physically facilitated penetration technology that utilizes a patch composed of multiple micron-sized tiny tips attached in an array to a base that is capable of penetrating the stratum corneum of the skin and placing the gene therapy drug directly on the epidermis or upper dermis to achieve localized or systemic therapeutic effects. Microneedle technology is not limited by molecular size, and microneedles can also be designed in a variety of forms, each of which can be tailored to specific delivery requirements. |
Technology: Gene therapy formulation drug delivery technology
Journal: Transl Respir Med
Published: 2014
Results: This article medium focuses on the early promise of aerosolized systemic drug delivery and its prospects for success. In addition, the challenges of aerosolized gene therapy and the need for suitable gene vectors will be discussed. Finally, progress in aerosolized vaccine development will be presented. The continued expansion of the role of aerosolized therapies in the future will depend on improving the bioavailability of systemically administered drugs, developing gene therapy vectors that can effectively penetrate mucus barriers and cell membranes, navigate in the cytoplasm, and efficiently transfer DNA material to the nucleus, improving the delivery of gene vectors and vaccines to infants, and developing formulations that are safe for both acute and chronic drug delivery.
CD Formulation provides comprehensive and reliable services in the development of gene therapy drug delivery systems to ensure the success of their programs. If you are interested in us, please feel free to contact us.
References
Laube BL. The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update. Transl Respir Med. 2014, 2:3.